14th

European Headache Federation Congress

EHF 2020Head over Ache:Silver Lining Novel Treatments

GENERAL INFORMATION

EHF invites to talk about Headache• EFIC I European Pain Federation• EMA I European Medicines Agency• LTB I Lifting the Burden of Headache Worldwide

Certi� cationAn application for CME Credits will be submitted to the EACCME (European Accreditation Council for Continuing Medical Education) once the scientifi c program is fi nalized. Additionally, an application will be handed in to the Medical Chamber of Berlin.

Industrial Participation The conference will host an exhibition, which will bring together manufacturers and suppliers in the fi eld of Headache Research and Migraine Therapy. Interested companies please contact Conventus.

We thank the following Companies for their Commitment*:

Platinum SponsorsEli Lilly and Company (Indianapolis, IN/US)

Novartis Pharma AG (Basel/CH)

Teva Pharmaceuticals Industries Ltd. (Petach Tikva/IL)

Gold SponsorAllergan AG (Dublin/IE)

Silver SponsorH. Lundbeck A/S(Valby/DK)

Symposium SponsorGrünenthal GmbH(Aachen/DE)

(state at printing)

Registration FeesThe online registration for the congress is possible viawww.ehf2020.com where the registration fees also can be found.

Professional Congress OrganizerConventus Congressmanagement & Marketing GmbHCyntia Rammel & Marlen Schillerehf2020@conventus.de I www.conventus.de

* We inform you about the fi nancial support of the congress by the member companies of the FSA e. V. (Freiwillige Selbstkontrolle für die Arzneimittelindustrie e.V.) via www.ehf2020.com.

JULY 3–5, 2020Berlin I Germany

CALL FOR ABSTRACTS

© jo

tily

l Fo

tolia

.co

m

GENERAL INFORMATION

VenueMaritim Hotel BerlinStauffenbergstrasse 26 I 10785 Berlin/DE

Hosting SocietyEuropean Headache Federation www.ehf-org.org

Congress ChairProfessor Zaza KatsaravaChief, Department of Neurology I Evangelical Hospital Unna/DEProfessor of Neurology I Medical Faculty, University of Essen/DE

Congress Co-ChairProfessor Richard B. LiptonDirector, Division of Cognitive Aging and DementiaDirector, Monte� ore Headache CenterAlbert Einstein College of Medicine I New York, NY/US Scienti� c Committee

Important Deadlines Abstract deadline February 16 Noti� cation of abstract acceptance March 25Early bird registration until April 15

Junior Scientifi c CommitteeF. Amin (Copenhagen/DK)S. Benemei (Florence/IT)C. Deen (Copenhagen/DK)Z. Dellaruelle (Ghent/BE)A. Doretti (Milano/IT)T. Dresler (Tübingen/DE)J. Edvinsson (Lund/SE)V. Favoni (Bologna/IT)

D. Garcia-Azorin (Villadolid/ES)A. Labastida Ramirez(Rotterdam/NL)M. Lisicki Martinez (Liège/BE)A. Negro (Rome/IT)A. Rubio-Beltran (Rotterdam/NL)N. Vandenbussche (Heverlee/BE)L. Vollesen (Copenhagen/DK)

M. Ashina (Copenhagen/DK)M. Braschinsky (Tartu/EE)R. Burstein (Boston, MA/US)A. Ducros (Montpellier/FR)Z. Katsarava (Essen/DE)J. Kruja (Tirana/AL)G. Lambru (London/GB)C. Lampl (Linz/AU)R. Lipton (Bronx, NY/US)A. Maassen van den Brink(Rotterdam/NL)

P. Martelletti (Rome/IT)P. Pozo Rozich (Barcelona/ES)U. Reuter (Berlin/DE)S. Sacco (L‘Aquila/IT)M. Sanchez del Rio (Madrid/ES)A. Sinclair (Birmingham/UK)M. Togha (Tehran/IQ)D. Yarnitzky (Haifa/IL)

in cooperation with

Travel grants for best abstract authors. Submit your researchand participate!

PROGRAM INFORMATION

Friday, July 308:00 Teaching Course 1 I Headache Clinics09:00 EHF meets EMA09:30 Coffee Break10:00 Sponsored Symposium 1 I Presented by ALLERGAN11:30 Poster Session 1 and Lunch11:45 Sponsored Symposium 2 I Presented by LUNDBECK13:00 EHF Lecture13:30 Scientifi c Session 1 I Clinical Research15:00 Coffee Break15:30 Sponsored Symposium 3 I Presented by NOVARTIS17:00 Poster of the Day17:30 Opening Ceremony with Public Lecture

Saturday, July 408:00 Teaching Course 2 I Headache Science09:00 Greppi Award Session09:30 Coffee Break10:00 Sponsored Symposium 4 I Presented by LILLY11:30 Poster Session 2 and Lunch13:00 EHF Lecture13:30 Scientifi c Session 2 I Cluster Headache15:00 Coffee Break15:30 Sponsored Symposium 6 I Presented by TEVA17:00 Poster of the Day17:30 Scientifi c Session 3 I Basic Research

HEADACHE DAY

from 08:30 EHF meets DMKG and DGS Special Program for Practitioners and Doctors’ Assistants11:45 Sponsored Symposium 5 l Presented by GRÜNENTHAL

Sunday, July 508:00 EHF and LTB08:45 Scientifi c Session 4 I Migraine10:15 Clinical trials in migraine11:00 Sponsored Symposium 712:00 EHF Clinical Guidelines12:30 EHF and EFIC13:15 Closing Ceremony and Awards

PROGRAM TOPICS• New treatments I Impact of CGRP targeted therapies in practice: Evidence from clinical trials and clinical practice Overview of approved and soon to be approved preventive treatments, real-world evidence on patterns of use and impact on outcomes• Prognostic biomarkers and individualized treatment I Identifying natural subgroups of people with migraine: Approaches to personalized medicine Review on the evidence that symptom profi les, comorbidity, triggers, treatment response, genetics, biomarkers and imaging can be used to identify natural subgroups of people with migraine and that those subgroups are useful in individualizing treatment and improving outcomes • New targets I Emphasizes the generation of mechanisms that will lead to the next generation of treatment • Regulatory and reimbursement science in headache medicine I EMA, FDA, NICE perspectives; Role of MBS as an acute treatment outcome • Latest and greatest headache science I Role of glymphatic system in migraine, mechanisms of individual symptoms such as nausea, photo, phono, etc. • “Headache day” for general practitioners and doctors’ assistants in cooperation with DMKG and DGS• Young scientifi c talents I EHF – School of Advanced Studies presents its work

ABSTRACT SUBMISSION & TRAVEL GRANTS

The European Headache Federation invites scientists and clini-cians for scienti� c exchange. We do our best to provide more room for the best science. We especially encourage young scientists to submit their best work. All posters will be evalu-ated by the scienti� c committee and the best posters will be presented at plenary sessions. The authors will receive free ac-cess to the congress and grants for travel and accommodation.

Abstract Topics• Basic research • Clinical research • Cluster headache• Migraine• Further topics

WELCOME NOTE

Dear ladies and gentlemen, dear colleagues,

We herewith cordially invite you to the 14th Congress of the European Headache Federation in Berlin.

New and exciting times are dawning, with a slew of new therapies underway: CGRP antibodies for migraine prophylaxis, lasmiditan as an alternative to triptans for acute therapy, atogepant, ubroge-pant, possibly PACAP antibodies and more. That is why we chose “Head over Ache: Silver Lining Novel Treatments” for the motto of the 14th European Headache Federation Congress.

Now we, physicians, psychologists, cost bearers, politicians, and those working in health care, must make sure that the new as well as the old treatments reach the right patients in the optimal way.We therefore invite doctors and scientists from Europe and abroad, but also our partners DMKG, DGS, EFIC, EMA, IHS and LTB to take part in this event.

We warmly welcome you to the Maritim Hotel from July 3–5, 2020 in wonderful Berlin, which is always worth a visit, especially at the beginning of summer! Together, let’s explore the future of headache treatment here in the capital of Germany. We remain in anticipation of interesting contributions and a pro� table discussion,

Yours sincerely,

Zaza Katsarava & Richard B. LiptonCongress chair & congress co-chair EHF 2020